Two new PET radiotracers have outperformed the only current Food and Drug Administration (FDA) approved radiotracer for ...

In vivo imaging of tau pathology will provide new insights into tau deposition in the human brain, thus facilitating research into causes, diagnosis and treatment of major dementias, such as ...

Enigma Biomedical USA Inc. has selected two four-repeat tau (4R tau) protein PET imaging biomarkers to advance into phase I studies. These imaging biomarkers show promise as important new tools in ...

In the subgroup of 44 patients with frontotemporal dementia who underwent MRI, those with a tau ratio below the cut-off value had significant clusters of reduced gray matter density in the brainstem.

Future Neurology. 2012;7(4):409-421. The growing body of research focused on the development of radiotracers for tau imaging is allowing researchers to distinguish specific radiotracer ...